Cargando…
Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline
Cabergoline (CAB), the first-line drug for treatment of prolactinomas, is effective in suppressing prolactin hypersecretion, reducing tumor size, and restoring gonadal function. However, mechanisms for CAB-mediated tumor shrinkage are largely unknown. Here we report a novel cytotoxic mechanism for C...
Autores principales: | Lin, Shao Jian, Leng, Zhi Gen, Guo, Yu Hang, Cai, Lin, Cai, Yu, Li, Ning, Shang, Han Bing, Le, Wei-Dong, Zhao, Wei Guo, Wu, Zhe Bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770775/ https://www.ncbi.nlm.nih.gov/pubmed/26513171 |
Ejemplares similares
-
Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively
por: Tang, Chao, et al.
Publicado: (2019) -
Hypo-Expression of Tuberin Promotes Adenomyosis via the mTOR1-Autophagy Axis
por: Gu, Ni-Hao, et al.
Publicado: (2021) -
mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014) -
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
por: Mangili, Federica, et al.
Publicado: (2022) -
Estrogen receptor β induces autophagy of osteosarcoma through the mTOR signaling pathway
por: Yang, Zhengming, et al.
Publicado: (2020)